Enables content for newly launched Illumina MiSeq™ i100 and expands Illumina oncology panel portfolio to include targeted liquid biopsy panels NATICK, Mass., Oct. 16, 2024 /PRNewswire/ — Pillar Biosciences, Inc., the leader in Decision Medicine™, has today announced an expansion of their…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.